These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23866012)

  • 1. Iron and iron chelators: a review on potential effects on skin aging.
    Pouillot A; Polla A; Polla BS
    Curr Aging Sci; 2013 Dec; 6(3):225-31. PubMed ID: 23866012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron as the malignant spirit in successful ageing.
    Polla AS; Polla LL; Polla BS
    Ageing Res Rev; 2003 Jan; 2(1):25-37. PubMed ID: 12437994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron chelators may help prevent photoaging.
    Kitazawa M; Iwasaki K; Sakamoto K
    J Cosmet Dermatol; 2006 Sep; 5(3):210-7. PubMed ID: 17177742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in iron chelation: an update.
    Heli H; Mirtorabi S; Karimian K
    Expert Opin Ther Pat; 2011 Jun; 21(6):819-56. PubMed ID: 21449664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin protection against UVA-induced iron damage by multiantioxidants and iron chelating drugs/prodrugs.
    Reelfs O; Eggleston IM; Pourzand C
    Curr Drug Metab; 2010 Mar; 11(3):242-9. PubMed ID: 20406189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a topical iron chelator in animals and in human beings: short-term photoprotection by 2-furildioxime.
    Bissett DL; Oelrich DM; Hannon DP
    J Am Acad Dermatol; 1994 Oct; 31(4):572-8. PubMed ID: 8089282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and neurodegeneration: the involvement of iron.
    Carocci A; Catalano A; Sinicropi MS; Genchi G
    Biometals; 2018 Oct; 31(5):715-735. PubMed ID: 30014355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ellagic acid isolated from Clerodendrum viscosum leaves ameliorates iron-overload induced hepatotoxicity in Swiss albino mice through inhibition of oxidative stress and the apoptotic pathway.
    Shendge AK; Basu T; Panja S; Chaudhuri D; Mandal N
    Biomed Pharmacother; 2018 Oct; 106():454-465. PubMed ID: 29990833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy by taking away: the case of iron.
    Polla BS
    Biochem Pharmacol; 1999 Jun; 57(12):1345-9. PubMed ID: 10353254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of iron chelation in free radical-induced oxidative stress and human disease.
    Jomova K; Valko M
    Curr Pharm Des; 2011; 17(31):3460-73. PubMed ID: 21902663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of iron in brain ageing and neurodegenerative disorders.
    Ward RJ; Zucca FA; Duyn JH; Crichton RR; Zecca L
    Lancet Neurol; 2014 Oct; 13(10):1045-60. PubMed ID: 25231526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of disease by selective iron depletion: a novel therapeutic strategy utilizing iron chelators.
    Hershko C
    Baillieres Clin Haematol; 1994 Dec; 7(4):965-1000. PubMed ID: 7881162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined administration of membrane-permeable and impermeable iron-chelating drugs attenuates ischemia/reperfusion-induced hepatic injury.
    Mantelou AG; Barbouti A; Goussia A; Zacharioudaki A; Papoudou-Bai A; Vlachou C; Kokkoris S; Papalois A; Galaris D; Glantzounis GK
    Free Radic Biol Med; 2022 Nov; 193(Pt 1):227-237. PubMed ID: 36243210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of ultraviolet light-induced oxidative stress by amino acid-based iron chelators.
    Kitazawa M; Iwasaki K
    Biochim Biophys Acta; 1999 Dec; 1473(2-3):400-8. PubMed ID: 10594377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the design of iron chelators against oxidative damage.
    Galey JB
    Mini Rev Med Chem; 2001 Sep; 1(3):233-42. PubMed ID: 12369970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway.
    Mandel SA; Avramovich-Tirosh Y; Reznichenko L; Zheng H; Weinreb O; Amit T; Youdim MB
    Neurosignals; 2005; 14(1-2):46-60. PubMed ID: 15956814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of iron chelators in the management of inflammatory disorders.
    Lehmann C; Islam S; Jarosch S; Zhou J; Hoskin D; Greenshields A; Al-Banna N; Sharawy N; Sczcesniak A; Kelly M; Wafa K; Cheliak W; Holbein B
    Mediators Inflamm; 2015; 2015():516740. PubMed ID: 25878400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic topical photoprotection by a combination of the iron chelator 2-furildioxime and sunscreen.
    Bissett DL; McBride JF
    J Am Acad Dermatol; 1996 Oct; 35(4):546-9. PubMed ID: 8859281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Fe(2+)- and Fe(3+)- induced hydroxyl radical production by the iron-chelating drug deferiprone.
    Timoshnikov VA; Kobzeva TV; Polyakov NE; Kontoghiorghes GJ
    Free Radic Biol Med; 2015 Jan; 78():118-22. PubMed ID: 25451643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron Chelation as Novel Treatment for Interstitial Cystitis.
    Hagn G; Westhofen R; Burkovskiy I; Holbein B; Zhou J; Lehmann C
    Pharmacology; 2019; 103(3-4):159-162. PubMed ID: 30695781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.